These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 26143402)

  • 21. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD; Luo L; Shults J
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
    Yatham LN; Fountoulakis KN; Rahman Z; Ammerman D; Fyans P; Marler SV; Baker RA; Carlson BX
    J Affect Disord; 2013 May; 147(1-3):365-72. PubMed ID: 23290791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
    Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
    Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
    J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
    Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
    Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.
    El-Mallakh RS; Marcus R; Baudelet C; McQuade R; Carson WH; Owen R
    J Affect Disord; 2012 Feb; 136(3):258-66. PubMed ID: 22209190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
    Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
    J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2010 Jun; 30(3):306-11. PubMed ID: 20473068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
    J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
    Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
    Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
    Amsterdam JD; Garcia-España F
    J Affect Disord; 2000 Sep; 59(3):225-9. PubMed ID: 10854639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.